Tag: Coloplast

Q. When is it time to challenge the status quo?   A. We cringe when we hear the phrase, “We’ve always done it that way.” Leaders know that change is constant and reliance on outdated methods can prove fatal to a business. However, when it comes to advocacy, many ask “What’s the use, it’ll never change?” It is easy to understand how people come to feel this way, as our industry is often overlooked and undervalued. However, the reality is that...

CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.  The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.  “Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...

MINNEAPOLIS – Coloplast has signed an agreement to buy Kerecis, a biotech company based in Iceland that is pioneering the use of fish skin in the regenerative medicine market, for up to $1.3 billion.  Coloplast will pay $1.2 billion upfront on a cash and debt-free basis and will pay up to a $100 million earnout dependent on financial performance in fiscal year 2023-24.  “The advanced wound care market holds significant untapped potential, and today Coloplast is only present...

Q. How can HME providers impact patient access?  A. In this post-pandemic world, patient access to home medical equipment continues to be threatened by increasing costs. Significant inflation (7.2% in 2022), shipping and supply chain costs, coupled with stagnant reimbursement, may pose challenges for providers to supply the high quality HME preferred by patients and prescribed by clinicians. Providers may assume an active role in improving patient access by actively reviewing payer contracts...

Q. How are consumer support programs beneficial to users and HMEs?   A. Manufacturer consumer support programs are free and often brand agnostic for individuals, health care professionals and HMEs. Trained advisers encourage compliance to practice guidelines for managing chronic health conditions. Resources include condition specific education, advice on lifestyle modification, product troubleshooting and tools to be successful. Typically, programs also provide product samples and help connect...

Q. What is market access and what is the value to me?  A. Pharma and biotech have long recognized the value of investing in market access to enable consumer access to therapies. As of recent, HME manufacturers have begun to invest in internal teams to address coverage and reimbursement restrictions with an overall goal of improving access for end-users. The work may take the form of advocacy on the federal level with CMS or with individual state Medicaid programs to improve coverage or reimbursement...

MINNEAPOLIS – A group of stakeholders that includes Coloplast has now succeeded in expanding coverage for ostomy supplies in 11 states.  Most recently, state Medicaid programs in three states have expanded coverage for ostomy supplies by increasing the number of codes they will reimburse: New Jersey (42 codes), Alabama (24 codes) and Georgia (16 codes).  “While gaps in coverage still exist in these states, this is significant progress for individuals with Medicaid,”...

WASHINGTON – AAHomecare is calling on providers to contact their members of Congress to sign on as original co-sponsors for draft legislation from by Rep. Markwayne Mullins, R.-Okla., and Paul Tonko, D-N.Y., that would provide reimbursement relief.  The legislation would apply 90/10 blended reimbursement rates for the 13 product categories that were removed from Round 2021 of Medicare’s competitive bidding program. The rates would apply from Jan. 1, 2022, through Dec. 31, 2023.  “A...

HUMLEBAEK, Denmark – Coloplast saw 6% organic growth in its first quarter ended Dec. 31. Reported revenue in DKK was up by 9% to DKK 5,169 million. Organic growth rates by business area were ostomy care 6%, continence care 5%, interventional urology 5% and wound & skin care 12%. EBIT before special items was DKK 1,649 million, a 7% increase from last year, corresponding to an EBIT margin before special items of 32% against 32% last year. EBIT after special items was DKK 1,615 million, a 5%...

MINNEAPOLIS - Coloplast has acquired IncoCare Gunhild Vieler GmbH, a direct-to-consumer provider of continence supplies, it announced today. The German company will strengthen Coloplast's presence in southeast Germany, according to a press release. “The acquisition of IncoCare is part of our strategy of pursuing inorganic opportunities to accelerate growth and to strengthen our service offering,” said Lars Rasmussen, Coloplast CEO. In December, Coloplast acquired SAS Lilial, a French...